UNSPSC 85131701: Pharmaceutical research services

In this classification, this commodity consists of comprehensive services required to be a pharmaceutical research service

UNSPSC 85131701 Pharmaceutical research services is a Commodity code under which state and local governments solicit independent medical evaluation, occupational health surveillance, pharmacy benefit administration, and related clinical assessment services. The recent opportunities posted under this code span medical review officer services for transit authorities, disability medical evaluation for public safety pension boards, occupational medical surveillance for state transportation agencies, pharmacy benefit management for county health systems, pharmaceutical consulting for workers' compensation agencies, and temporary clinical staffing qualification pools for county health systems. This breadth reflects how state and local procurement offices tag clinically oriented services and expert consultation work that may not strictly constitute research but falls within the code's broad scope.

Issuing bodies include transit authorities (Dallas Area Rapid Transit Authority), municipal retirement offices (City of Phoenix), state transportation departments (Washington State Department of Transportation), county commissioners and health systems (Collier County, Santa Clara County), and state labor and workers' compensation agencies (California Department of Industrial Relations Division of Workers' Compensation). Geographic activity spans Washington, Arizona, California, Florida, Texas, and Illinois. Representative recent opportunities include Dallas Area Rapid Transit Authority's RFQ for Medical Review Officer services due October 5, 2026; City of Phoenix Retirement Office's RFP for independent medical evaluation services with a $750,000 five-year maximum contract value due October 16, 2026; Washington State Department of Transportation's RFP for occupational medical surveillance across 14 ferry system locations due October 9, 2026 with a pre-bid conference on August 31, 2026; and California Department of Industrial Relations' RFP for pharmaceutical consulting expertise supporting the Medical Treatment Utilization Schedule due August 3, 2026 with a $332,000 initial 36-month firm-fixed-price contract.